These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6204430)

  • 1. Tumor-associated antigens in female genital tract cancers.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R
    Tumori; 1984 Jun; 70(3):281-9. PubMed ID: 6204430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic heterogeneity of human lung cancers.
    Harłozińska A; Richter R; Albert Z; Zawadzka H
    J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical carcinoma antigen, carcinoembryonic antigen (CEA), and nonspecific cross-reacting antigen (NCA) in appraisal of uterine cervix smears.
    Harlozinska A; Kula J; Stepinska B; Jelen M; Richter R; Slesak B
    Am J Clin Pathol; 1985 Mar; 83(3):301-7. PubMed ID: 3883744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M
    Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of substances related to carcinoembryonic antigens, CEA-NCA and association with alpha1-antichymotrypsin.
    Orjasaeter H
    Acta Pathol Microbiol Scand C; 1976 Jun; 84(3):235-44. PubMed ID: 63223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
    Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
    Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen in cancer of the female reproductive system: its detection in serum by a microradioimmunoassay.
    Khoo SK; Mackay EV
    Aust N Z J Obstet Gynaecol; 1973 May; 13(2):107-13. PubMed ID: 4518714
    [No Abstract]   [Full Text] [Related]  

  • 14. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two CEA cross-reacting antigens: differences in absorbing the same anti-CEA serum.
    Ferrara RM; Biancardi C; Cavalca V; Botta M; Bailo M; Bartorelli A
    Cancer Detect Prev; 1987; 10(1-2):101-8. PubMed ID: 3568003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
    Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
    Bhattacharya M; Barlow JJ; Chu TM; Piver MS
    Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinoembryonic antigen in patients with gynecologic malignancies.
    DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
    Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian tumor antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1978 Sep; 42(3 Suppl):1616-20. PubMed ID: 81712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.